Things fall apart with hepatocellular carcinoma and direct-acting antivirals

被引：3
作者：
Kutala, Blaise [1 ,2 ]
Valla, Dominique [1 ]
Marcellin, Patrick [1 ]
机构：
[1] Beaujon Univ Hosp Paris Nord, DHU Unity, Dept Hepatol, Clichy, France
[2] Univ Paris Diderot, INSERM, Inflammat Res Ctr, UMR 1149, Paris, France
来源：
EXPERT OPINION ON DRUG SAFETY | 2018年 / 17卷 / 02期
关键词：
HCC; SVR; DAAs; incidence; recurrence; C VIRUS-INFECTION; INTERFERON-FREE THERAPY; ERADICATION; RECURRENCE; SYSTEM; RISK; HCC;
D O I：
10.1080/14740338.2018.1404026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：107 / 109
页数：3
相关论文
共 20 条
[1]   Clinicopathological analysis of CD8-positive lymphocytes in the tumor parenchyma and stroma of hepatocellular carcinoma [J].
An, Jun-Ling ;
Ji, Qiao-Hong ;
An, Ji-Jiang ;
Masuda, Shinji ;
Tsuneyama, Koichi .
ONCOLOGY LETTERS, 2014, 8 (05) :2284-2290
[2]   Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts [J].
不详 .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :734-740
[3]   The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience [J].
Bielen, R. ;
Moreno, C. ;
Van Vlierberghe, H. ;
Bourgeois, S. ;
Mulkay, J. -P. ;
Vanwolleghem, T. ;
Verlinden, W. ;
Brixco, C. ;
Decaestecker, J. ;
de Galocsy, C. ;
Janssens, F. ;
Van Overbeke, L. ;
Van Steenkiste, C. ;
D'Heygere, F. ;
Cool, M. ;
Wuyckens, K. ;
Nevens, F. ;
Robaeys, G. .
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (11) :976-981
[4]  
Camma C, 2017, J HEPATOL, V9
[5]   Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments [J].
Cariani, Elisabetta ;
Pilli, Massimo ;
Barili, Valeria ;
Porro, Emanuela ;
Biasini, Elisabetta ;
Olivani, Andrea ;
Dalla Valle, Raffaele ;
Trenti, Tommaso ;
Ferrari, Carlo ;
Missale, Gabriele .
ONCOIMMUNOLOGY, 2016, 5 (08)
[6]   Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals [J].
Conti, Fabio ;
Buonfiglioli, Federica ;
Scuteri, Alessandra ;
Crespi, Cristina ;
Bolondi, Luigi ;
Caraceni, Paolo ;
Foschi, Francesco Giuseppe ;
Lenzi, Marco ;
Mazzella, Giuseppe ;
Verucchi, Gabriella ;
Andreone, Pietro ;
Brillanti, Stefano .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :727-733
[7]   A critical function for type I interferons in cancer immunoediting [J].
Dunn, GP ;
Bruce, AT ;
Sheehan, KCF ;
Shankaran, V ;
Uppaluri, R ;
Bui, JD ;
Diamond, MS ;
Koebel, CM ;
Arthur, C ;
White, JM ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2005, 6 (07) :722-729
[8]   Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response [J].
Feld, Jordan J. ;
Nanda, Santosh ;
Huang, Ying ;
Chen, Weiping ;
Cam, Maggie ;
Pusek, Susan N. ;
Schweigler, Lisa M. ;
Theodore, Dickens ;
Zacks, Steven L. ;
Liang, T. Jake ;
Fried, Michael W. .
HEPATOLOGY, 2007, 46 (05) :1548-1563
[9]   The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor [J].
Gasser, S ;
Orsulic, S ;
Brown, EJ ;
Raulet, DH .
NATURE, 2005, 436 (7054) :1186-1190
[10]   MICA SNPs and the NKG2D system in virus-induced HCC [J].
Goto, Kaku ;
Kato, Naoya .
JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) :261-272
12